Search: onr:"swepub:oai:DiVA.org:kth-195263" >
Targeting HER3 usin...
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds
-
- Malm, Magdalena (author)
- KTH,Proteinteknologi,KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.
-
- Frejd, Fredrik Y. (author)
- Uppsala universitet,Medicinsk strålningsvetenskap,Affibody AB, Stockholm, Sweden.
-
- Ståhl, Stefan (author)
- KTH,Proteinteknologi,KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.
-
show more...
-
- Löfblom, John (author)
- KTH,Proteinteknologi,KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.
-
show less...
-
(creator_code:org_t)
- 2016-09-08
- 2016
- English.
-
In: mAbs. - : Taylor & Francis. - 1942-0862 .- 1942-0870. ; 8:7, s. 1195-1209
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://www.tandfonl...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- The human epidermal growth factor receptor 3 (HER3) has in recent years been recognized as a key node in the complex signaling network of many different cancers. It is implicated in de novo and acquired resistance against therapies targeting other growth factor receptors, e.g., EGFR, HER2, and it is a major activator of the PI3K/Akt signaling pathway. Consequently, HER3 has attracted substantial attention, and is today a key target for drugs in clinical development. Sophisticated protein engineering approaches have enabled the generation of a range of different affinity proteins targeting this receptor, including antibodies and alternative scaffolds that are either mono- or bispecific. Here, we describe HER3 and its role as a key tumor target, and give a comprehensive review of HER3-targeted proteins currently in development, including discussions on the opportunities and challenges of targeting this receptor.
Subject headings
- NATURVETENSKAP -- Biologi (hsv//swe)
- NATURAL SCIENCES -- Biological Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
Keyword
- Affibody molecules
- alternative scaffolds
- bispecific antibodies
- ErbB3
- HER3
- monoclonal antibodies
- protein therapeutics
- tumor targeting
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
mAbs
(Search for host publication in LIBRIS)
To the university's database